Complete remission after first-line radio-chemotherapy as predictor of survival in extranodal NK/T cell lymphoma
2012 · Journal of Hematology & Oncology · 35 citations
https://doi.org/10.1186/1756-8722-5-27
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
25
Papers
212
Citations
8
h-index
7
i10-index
Isabelle Bedgedjian is an academic researcher from Centre Hospitalier Universitaire de Besançon. The author has contributed to research in topics: Lymphoma Diagnosis and Treatment & Bladder and Urothelial Cancer Treatments & Viral-associated cancers and disorders. The author has an h-index of 8, co-authored 22 publications.
https://doi.org/10.1186/1756-8722-5-27
https://doi.org/10.1186/s12885-018-5137-4
https://doi.org/10.1016/j.annpat.2015.12.001
Click to start Chat